WHO, FDA registered Antimalarial, Pyramax approved for coronavirus clinical trials
South Africa in the news: WHO, FDA registered Antimalarial, Pyramax approved for coronavirus clinical trials: The World Health Organisation prequalified and Ghana Food and Drugs Authority registered Antimalarial Pyramax (Artesunate-Pyronaridine), a fixed-dose combination medication for the treatment of …: “South Africa” – BingNews Starting XIs: Wydad v Chiefs: Kaizer Chiefs will look for their first-ever …
